Shanghai Haohai Biological Technology Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 611.25 million compared to CNY 473.62 million a year ago. Net income was CNY 81.18 million compared to CNY 60.94 million a year ago.

Basic earnings per share from continuing operations was CNY 0.47 compared to CNY 0.35 a year ago. Diluted earnings per share from continuing operations was CNY 0.47 compared to CNY 0.35 a year ago.